Résultat de recherche

Copy of Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Health technology assessment - Posted on 04/12/2020

Add to my selection

Copy of Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Health technology assessment - Posted on 04/12/2020

Add to my selection

Copy of Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Health technology assessment - Posted on 10/11/2020

Add to my selection

Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Health technology assessment - Posted on 19/10/2020

Add to my selection

Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Health technology assessment - Posted on 16/04/2020 - Mis à jour le 18/5/2020

Download document

Add to my selection

Clinical utility of genomic signatures in early-stage breast cancer - INAHTA Brief

Health technology assessment - Posted on 11/02/2019

Download document

Add to my selection

Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) - INAHTA Brief

Health technology assessment - Posted on 18/12/2018

Download document

Add to my selection

Updating of medical pathology procedures concerning the diagnosis of cysticercosis - INAHTA Brief

Health technology assessment - Posted on 05/07/2018 - Mis à jour le 5/7/2018

Download document

Add to my selection

Updating of medical pathology procedures concerning the diagnosis of trichinellosis - INAHTA Brief

Health technology assessment - Posted on 05/07/2018

Download document

Add to my selection

Updating of medical pathology procedures concerning the diagnosis of fasciolosis - INAHTA Brief

Health technology assessment - Posted on 05/07/2018 - Mis à jour le 6/7/2018

Download document

Add to my selection

My account

You do not have a saved search

No element in selection

64 results

Drugs, devices and medical acts

Copy of Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Copy of Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Copy of Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Specifications setting out the performance assessment methods applicable to serological tests detecting anti-SARS-CoV-2 antibodies

Clinical utility of genomic signatures in early-stage breast cancer - INAHTA Brief

Screening for dihydropyrimidine dehydrogenase deficiency to decrease the risk of severe toxicities related to fluoropyrimidines (5-fluorouracil or capecitabine) - INAHTA Brief

Updating of medical pathology procedures concerning the diagnosis of cysticercosis - INAHTA Brief

Updating of medical pathology procedures concerning the diagnosis of trichinellosis - INAHTA Brief

Updating of medical pathology procedures concerning the diagnosis of fasciolosis - INAHTA Brief

Follow us :